Extract
Sleep apnoea syndrome (SAS) is a common sleep disorder with a prevalence ranging from 5.9% to 79.2% in the European general population over 40 years of age, depending on the clinical symptoms and apnoea hypopnoea scoring criteria used [1]. Despite its frequency, the fact that it is a significant risk factor for many common diseases, and a recent meta-analysis demonstrating that available treatments are effective [2], SAS remains underdiagnosed.
Abstract
Mandibular movement tests have demonstrated potential as screening tools for polysomnography candidates http://ow.ly/iu2430fZk2u
Acknowledgements
Data were provided by the Brizzy registry (Nomics, Belgium). However, Nomics was in no way involved in this analysis, nor did they provide any kind of incentive to any of the authors.
Footnotes
Clinical trial: This study is registered at clinicaltrials.gov with identifier number NCT03129984.
Conflict of interest: None declared.
- Received May 27, 2017.
- Accepted September 6, 2017.
- Copyright ©ERS 2017